|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (3Y Monthly)||4.34|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CANAQUEST MEDICAL CORP (fka ALGAE DYNAMICS CORP) (OTC: “ADYNF”) (the "Company" or “CanaQuest”), a company developing unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, has filed two provisional patents which stem from its sponsored research program at Western University in London, Ontario, Canada. The provisional patents cover the United States and Canada. The provisional patents cover a unique formulation utilizing the cannabis cannabinoid, THC, and a botanical extract to treat various psychiatric disorders, with the unique feature of elimination of the negative side effects associated with THC such as euphoria.
CanaQuest Medical Corp. (OTC: “ADYNF”), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, and Jamaican Medical Cannabis Corporation (JMCC), a Toronto-headquartered company with rapidly expanding cannabis cultivation, processing and distribution operations in Jamaica, announced today that they have signed a preliminary agreement under which JMCC will exclusively provide Jamaican-based processing, packaging, warehousing and global distribution services for CanaQuests'’ new cannabinoid-rich mental health and nutraceutical products. As previously announced on August 2, 2018, the two companies completed a supply agreement under which JMCC will supply cannabis for medicinal use by CanaQuest or its nominated third-party permitted buyers.
ALGAE DYNAMICS CORP (OTC: “ADYNF”) (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oils, today announced it has changed its name to CanaQuest Medical Corp to better reflect its new strategic direction. The strategic direction reflected in the name CanaQuest Medical Corp is the development, manufacture and worldwide distribution of formulations that combine the significant health benefits of Omega-3 essential fatty acids derived from algae oil and extracts of cannabis and botanical oils. The formulations that we have developed, and are continuing to develop, stem from sponsored research at Western University and the University of Waterloo in London and Waterloo, Ontario, Canada, respectively.